Home
Seyfarth Shaw LLP
Parithosh Tungaturthi
Parithosh Tungaturthi
Seyfarth Shaw LLP
Teva Sues FDA Alleging Unlawful Interpretation Of The Definition Of "First Applicant"
29 Oct 2018 | United States
USPTO Director Proposes New Patent Eligibility Guidance
16 Oct 2018 | United States
Now Available! Seyfarth Shaw's Bioloquitur Bulletin: Drugs Available In 2018 For Generic Competition
11 Apr 2018 | United States
Good ANDA Submission Practices: Summary Of Draft Guidance
04 Apr 2018 | United States
2017 Patent Litigation: A Statistical Overview
16 Mar 2018 | United States
Innovation In Hatch-Waxman And ANDA Litigation
14 Mar 2018 | United States
FDA Releases Draft Guidance On Determining Whether To Submit An ANDA Or A 505(b)(2) Application
06 Dec 2017 | United States
Contact Details
Email Website
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.